- Investing Ideas
- /
- Global Can They Turn the Tide
Global Can They Turn the Tide
UPDATED Apr 23, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
211 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ITCI | US$74.00 | -7.3% | 21.7% | US$7.8b | US$90.28 | PS16.6x | E58.8% | n/a | Pharmaceuticals & Biotech | ||
BIO | US$285.28 | -2.6% | -34.8% | US$8.0b | US$428.90 | PS3x | E81.3% | n/a | Pharmaceuticals & Biotech | ||
FIVN | US$58.25 | 2.7% | -6.5% | US$4.3b | US$84.79 | PS4.7x | E64.4% | n/a | Software | ||
MHK | US$113.44 | 3.6% | 18.8% | US$7.0b | US$125.83 | PB1x | E46.2% | n/a | Consumer Durables | ||
PINS | US$33.02 | 1.0% | 19.0% | US$22.3b | US$43.05 | PS7.4x | E40.8% | n/a | Media | ||
PCOR | US$71.73 | -1.7% | 37.3% | US$10.2b | US$87.24 | PS10.9x | E46.1% | n/a | Software | ||
MDGL | US$218.38 | -6.3% | -26.2% | US$4.5b | US$377.07 | PB11.3x | E61.4% | n/a | Pharmaceuticals & Biotech | ||
TEAM | US$199.44 | 2.4% | 39.4% | US$50.4b | US$257.65 | PS13.3x | E42.8% | n/a | Software | ||
SONO | US$17.71 | 4.6% | -12.7% | US$2.1b | US$23.48 | PS1.4x | E58.7% | n/a | Consumer Durables | ||
CWAN | US$16.68 | 2.8% | 4.6% | US$4.1b | US$22.22 | PS9.9x | E129.1% | n/a | Software | ||
FLNC | US$16.25 | 1.2% | -14.9% | US$2.8b | US$30.38 | PB5x | E65.3% | n/a | Capital Goods | ||
VCEL | US$45.38 | -4.5% | 52.7% | US$2.2b | US$53.90 | PS11.1x | E49.3% | n/a | Pharmaceuticals & Biotech | ||
IOVA | US$11.32 | -5.0% | 105.4% | US$3.2b | US$26.00 | PS2659.2x | E61.7% | n/a | Pharmaceuticals & Biotech | ||
VERX | US$30.04 | 0.7% | 43.5% | US$4.6b | US$37.20 | PS8.1x | E77.6% | n/a | Software | ||
BGNE | US$139.12 | 3.8% | -43.6% | US$13.7b | US$268.64 | PS5.9x | E56.2% | n/a | Pharmaceuticals & Biotech | ||
MNDY | US$184.79 | -1.7% | 55.2% | US$8.9b | US$244.93 | PS12.4x | E38.8% | n/a | Software | ||
CLSK | US$20.71 | 43.0% | 464.3% | US$4.3b | US$23.33 | PS21.8x | E82.4% | n/a | Software | ||
GDRX | US$6.97 | 6.9% | 27.0% | US$2.5b | US$8.68 | PS3.5x | E40.4% | n/a | Healthcare | ||
NEWR | US$86.99 | 0.09% | 47.3% | US$6.2b | US$86.30 | PS6.4x | E123.8% | n/a | Software | ||
PRVB | US$24.98 | 2.7% | 456.3% | US$2.4b | US$24.00 | PS183.6x | E75.7% | n/a | Pharmaceuticals & Biotech | ||
IDS | UK£2.75 | 28.6% | 11.1% | UK£2.6b | UK£2.80 | PB0.9x | E118.7% | 0% | Transportation | ||
PATH | US$19.55 | 0.7% | 35.6% | US$10.7b | US$27.89 | PS8.5x | E72.1% | n/a | Software | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | Pharmaceuticals & Biotech | ||
BPT | AU$1.60 | -1.2% | 9.6% | AU$3.6b | AU$1.90 | PS2.1x | E60.2% | 2.5% | Energy |